Delayed Antibiotic Therapy in Non-severe Ventilator Acquired Pneumonia (VAP)
DELAVAP
Aggressive Versus Restrictive Initiation of Antimicrobial Treatment in Critically Ill Patients With Suspected Ventilator Acquired Pneumonia Without Severity : a Before and After Observational Study
1 other identifier
observational
87
1 country
1
Brief Summary
This retro-prospective monocentric observational study compare the impact of the implementation of a restrictive (delayed) versus aggressive (immediate) antibiotic strategy for Ventilator Acquired Pneumonia suspicion without severity symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 6, 2022
CompletedFirst Submitted
Initial submission to the registry
January 11, 2022
CompletedFirst Posted
Study publicly available on registry
January 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 28, 2023
CompletedMarch 8, 2023
March 1, 2023
1.1 years
January 11, 2022
March 7, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
antibiotic-free days
antibiotic-free days until Day 28 of Intensive Care Units stay
28 days
Secondary Outcomes (4)
Mechanical ventilation free days
28 days
Intensive care unit stay length
28 days
Intensive care unit mortality
28 days
Hospitality mortality
28 days
Study Arms (2)
Restrictive antibiotic strategy
Aggressive (immediate) antibiotic strategy
Interventions
Implementation of a restrictive (delayed) antibiotic strategy in Ventilator Acquired Pneumonia suspicion without severity symptoms.
Implementation of an aggressive (immediate) antibiotic strategy in Ventilator Acquired Pneumonia suspicion without severity symptoms.
Eligibility Criteria
patient under mechanical ventilation in intensive care with suspected ventilator acquired pneumonia
You may qualify if:
- Under mechanical ventilation from more than 48 hours
- Suspected for a ventilator acquired pneumonia, requiring a distal pulmonary bacterial sample
You may not qualify if:
- New or worsening shock requiring vasopressor
- New or worsening severe hypoxemia (PaO2/FiO2\<150 in FiO2≥60% and peep 10)
- Patient under veno-veinous extracorporeal membrane oxygenation
- Neutropenia \<1G/L or immunosuppressive treatment (including corticosteroids \>6 months or \>0.5mg/kg/j)
- Disease (endocarditis, spondylodyscitis, deep abcedation…) requiring prolonged antibiotic therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Nantes Hospital
Nantes, 44000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- OTHER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 11, 2022
First Posted
January 25, 2022
Study Start
January 6, 2022
Primary Completion
January 28, 2023
Study Completion
January 28, 2023
Last Updated
March 8, 2023
Record last verified: 2023-03